Literature DB >> 17266636

Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome.

S Kralisch1, M Bluher, R Paschke, M Stumvoll, M Fasshauer.   

Abstract

The role of adipocytes has been recently better understood. Several adipocytokines have been identified, including leptin, a main regulator of appetite and energy expenditure, adiponectin and others, as novel insulin-sensitizers/insulin-mimetics, and some others inducing insulin resistance. Adipocytokines thus represent interesting novel drug targets in the future management of obesity.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17266636     DOI： 10.2174/138955707779317821

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN： 1389-5575            Impact factor:   3.862


  18 in total

Review 1.  Adipose tissue: the new endocrine organ? A review article.

Authors:  Susan E Wozniak; Laura L Gee; Mitchell S Wachtel; Eldo E Frezza
Journal:  Dig Dis Sci       Date:  2008-12-04       Impact factor: 3.199

Review 2.  Vaspin in obesity and diabetes: pathophysiological and clinical significance.

Authors:  Matthias Blüher
Journal:  Endocrine       Date:  2011-12-03       Impact factor: 3.633

Review 3.  Gender differences in cardiovascular disease: hormonal and biochemical influences.

Authors:  Faustino R Pérez-López; Luis Larrad-Mur; Amanda Kallen; Peter Chedraui; Hugh S Taylor
Journal:  Reprod Sci       Date:  2010-06       Impact factor: 3.060

Review 4.  Fat fibrosis: friend or foe?

Authors:  Ritwik Datta; Michael J Podolsky; Kamran Atabai
Journal:  JCI Insight       Date:  2018-10-04

5.  Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine.

Authors:  Siegfried Ussar; Olivier Bezy; Matthias Blüher; C Ronald Kahn
Journal:  Diabetes       Date:  2012-06-29       Impact factor: 9.461

6.  New and emerging agents in the management of lipodystrophy in HIV-infected patients.

Authors:  Eric Bonnet
Journal:  HIV AIDS (Auckl)       Date:  2010-09-17

7.  Roles of IL-6-gp130 Signaling in Vascular Inflammation.

Authors:  Tieying Hou; Brian C Tieu; Sutapa Ray; Adrian Recinos Iii; Ruwen Cui; Ronald G Tilton; Allan R Brasier
Journal:  Curr Cardiol Rev       Date:  2008-08

Review 8.  YKL-40--an emerging biomarker in cardiovascular disease and diabetes.

Authors:  Camilla N Rathcke; Henrik Vestergaard
Journal:  Cardiovasc Diabetol       Date:  2009-11-23       Impact factor: 9.951

9.  Benefits of leptin therapy in HIV patients.

Authors:  Uma Sinha; Keshab Sinharay; Nilanjan Sengupta; Prasanta Mukhopadhyay
Journal:  Indian J Endocrinol Metab       Date:  2012-12

10.  SoSoSo or its active ingredient chrysophanol regulates production of inflammatory cytokines & adipokine in both macrophages & adipocytes.

Authors:  Hong-Kun Rim; Phil-Dong Moon; In-Hwa Choi; Eun-Hee Lee; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.